4 Results for "

BRCA wild-type

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "BRCA wild-type" in MCE Product Catalog:

Cat. No.: HY-162477
CAS No.: 1563260-97-8
Target:  

Cathepsin Apoptosis

Research Areas:  

Cancer

TS-24 is an inhibitor for cathepsin S, with an IC50 of 4.3 μM. TS-24 exhibits radiosensitizing activity in wild type breast cancer susceptibility gene 1 (BRCA1) and in TNBC xenograft mice model, through induction of apoptosis .
loading...
    loading...
Cat. No.: HY-132885
CAS No.: 2687273-52-3
Research Areas:  

Cancer

PARP/EZH2-IN-1 is a first-in-class dual PARP-1/EZH2 inhibitor with IC50 values of 6.87 nM and 36.51 nM, respectively. PARP/EZH2-IN-1 induces autophagy in cancer cells and shows potent antiproliferative activity in BRCA wild-type triple-negative breast cancer cells .
loading...
    loading...
Cat. No.: HY-155965
CAS No.: 3010256-54-6
Target:  

VEGFR PARP Apoptosis

Research Areas:  

Cancer

VEGFR/PARP-IN-1 (Compound 14b) is a VEGFR/PARP dual inhibitor (IC50s: 191 nM and 60.9 nM respectively). VEGFR/PARP-IN-1 inhibits DNA damage repair, induces cell apoptosis, and arrests cell in the G2/M phase. VEGFR/PARP-IN-1 has good antiproliferative efficacy against BRCA wild-type breast cancer cells (IC50: 4.1 and 3.5 μM for MDA-MB-231 and MCF-7 cells). VEGFR/PARP-IN-1 is an antitumor and anti-metastasis agent .
loading...
    loading...
Cat. No.: HY-181928
CAS No.: 3123529-62-1
Target:  

c-Met/HGFR PARP Apoptosis

Research Areas:  

Cancer

PARP1/c-Met-IN-3 (Compound L19) is a selective c-Met and PARP1 inhibitor, with an IC50 of 5.4 nM against c-Met and an IC50 of 3.7 nM against PARP1. PARP1/c-Met-IN-3 inhibits PARP2 enzymatic activity with an IC50 of 4.52 nM, and shows no specificity for PARP1 and PARP2. PARP1/c-Met-IN-3 induces cell cycle arrest and apoptosis. PARP1/c-Met-IN-3 exhibits anti-tumor activity against triple-negative breast cancer .
loading...
    loading...